Lumena suspends trading, delays report amid claims of 'misrepresenting' financials

By Steve Toloken
Staff Reporter / Asia Bureau Chief

Published: April 18, 2014 10:19 am ET
Updated: April 18, 2014 10:22 am ET

Related to this story

Topics Materials, Materials Suppliers, China

China Lumena New Materials Corp., which says it has the world's largest manufacturing capacity for polyphenylene sulfide resin, has suspended its stock trading and delayed its annual financial report after being hit with allegations it dramatically overstated sales.

The Chengdu, Sichuan Province-based Lumena denies the allegations, contained in two recent reports from analysts that accused the company of making “numerous material misrepresentations,” including that its sales and profits from PPS were 90 percent less than it claimed.

Lumena, in an April 4 filing to the Hong Kong Stock Exchange, strongly disputed the claims made by Glaucus Research Group and Emerson Analytics.  It said Glaucus stood to gain financially if Lumena's share price dropped, a point which Glaucus, a short-selling investor, acknowledged in its report.

“The Company believes the allegations made in the [Glaucus] report to be without merit and not supported by evidence,” said Lumena Chairman Zhang Zhigang, in a statement. “The Company is seeking legal advice from its legal advisers and reserves its rights to take legal actions against Glaucus and Emerson Analytics.”

But the two reports are not the first time similar questions have been raised about Lumena.

A 2011 story in the specialized financial news service Debtwire pointed out large differences between Lumena's financials reported in Chinese tax filings to the State Administration of Industry and Commerce and figures given to the Hong Kong Stock Exchange for another company unit processing the mineral thenardite.

The company said it was based on discrepancies between preliminary electronic tax filings and official filings. That story was also published on the website of the Financial Times newspaper.

Lumena initially planned to issue its 2013 full-year financial report March 28, but after the Glaucus report came out March 25, and then the Emerson report April 1, it said it was delaying that until it responded in full to both. Its shares remain suspended from trading.

Glaucus said its 24-page report was based on reviews of publicly-available Chinese tax records, which it said show that Lumena reported only 181 million Chinese yuan ($29.1 million) of income from its PPS business in 2012, 91 percent less than it reported to the Hong Kong stock market.

“The [Chinese government] filings suggest that not only is Lumena fabricating PPS revenue, but that the Company overpaid for the RMB 10 billion ($1.6 billion) acquisition of the PPS business from the former Chairman and other shareholders in 2011,” Glaucus said.

Lumena paid for the purchase with 10 percent in cash and 90 percent in stock.

Emerson issued a 43-page report April 1 that argues, based on observations of its production plants and estimates of capacity based on information from its raw material and equipment suppliers, that Lumena's PPS resin production is about 5,000 tons, or about 18 percent of what the company claims.

Lumena, in its April 4 filing with the Hong Kong market, said the Glaucus report contained incorrect information and that its two business units making PPS reported 2.93 billion Chinese yuan ($471 million) in revenue in 2012.

It said those tax documents would be available for inspection at its Hong Kong office on working days until April 30.

“The Company wishes to point out that the financial information of Sichuan Deyang Chemical set out in the Glaucus Report was wrong and without basis,” Lumena said.

“The substantial discrepancies between the financial information contained in the Glaucus Report and the Group's actual circumstances have demonstrated that Glaucus does not even have the most basic understanding of the Group's operations,” Lumena said.

Lumena said it would respond in detail to the Emerson allegations later.

Lumena and DSM Engineering Plastics in May 2012 announced that they were in talks about jointly marketing some grades of engineering plastics and developing alloys of PPS and polyamide resin.

In May 2013, a DSM executive said at the Chinaplas trade show that the two companies remained in “intensive discussions” about a partnership. DSM did not respond to an email and telephone call about the status of those talks.

Lumena did not respond to a phone call and email.

Glaucus also noted that the credit rating agency Moody's withdrew its rating of Lumena in December, which Glaucus said could make it harder for Lumena to refinance $120 million debt due in mid-May.

Moody's said in a statement only that it ''has withdrawn the rating for its own business reasons.''

Lumena did not address the Moody's rating in its filing but said its financials were audited in accordance with the rules of the Hong Kong stock exchange.

In March, the company said in a statement that a new 25,000 metric ton PPS resin production line would begin trial production in June, boosting its total capacity to 55,000 metric tons. The company said it will add another PPS production line this year.


Comments

Lumena suspends trading, delays report amid claims of 'misrepresenting' financials

By Steve Toloken
Staff Reporter / Asia Bureau Chief

Published: April 18, 2014 10:19 am ET
Updated: April 18, 2014 10:22 am ET

Post Your Comments


Back to story


More stories

Image

Dow reaches agreement with Third Point

November 21, 2014 9:11 am ET

Dow Chemical Co. has reached an agreement with the investment firm that has been trying to force the company to sell off some assets.More

Image

Ineos making its UK shale play

November 21, 2014 9:29 am ET

Chemical giant Ineos Group AG is planning to be the biggest player in the United Kingdom's shale gas industry.    More

Image

Total to buy majority stake in Polyblend

November 20, 2014 10:04 am ET

French oil and gas giant Total SA will buy a 68 percent stake in Germany's Polyblend GmbH, a subsidiary of Polymer-Chemie GmbH.    More

Image

Molder Carclo expands in China, chasing medical growth

November 19, 2014 3:44 pm ET

U.K.-based injection molder Carclo plc is “significantly” expanding its Chinese medical manufacturing capacity with a new factory, as the ...    More

Image

Silica can replace plastic microbeads

November 19, 2014 6:00 am ET

As cosmetics and soap makers face pressure to remove plastic microbeads from their products, Evonik Industries touts its new silica-based microbeads a...    More

Market Reports

Plastics in Brazil - State of the Industry Report

This in-depth report examines the Brazilian plastics industry from a historical and geographical context. Our analysts provide insight on economic trends and forecasts, growing manufacturing sectors that utilize plastics, private investment opportunities, market environment challenges, and innovations in R&D.

Data tables and charts on producer prices, trade, plastics production and end market indicators is also included.

Learn more

Plastics Recycling Trends in North America

This report is a review and analysis of the North American Plastics Recycling Industry, including key trends and statistics based on 2013 performance. We examine market environment factors, regulatory issues, industry challenges, key drivers and emerging trends in post-consumer and post-industrial recycling.

Learn more

Injection Molders Market Report & Ranking 2014

This special package contains our 132-page 2014 Market Report on the Injection Molding segment and our exclusive 2014 RANKINGS database of 500+ Injection Molders for a discounted package price.

Learn more

Upcoming Plastics News Events

January 14, 2015 - January 14, 2015Plastics in Automotive

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

June 2, 2015 - June 3, 2015Plastics Financial Summit - Chicago 2015

September 16, 2015 - September 18, 2015Plastics Caps & Closures - September 2015

October 27, 2015 - October 29, 2015Plastics Financial Summit - New York - 2015

More Events